DepoMed, Inc. (DEPO) Misses Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts DEPO Hot Sheet
Join SI Premium – FREE
DepoMed, Inc. (NASDAQ: DEPO) reported Q2 EPS of ($0.11), $0.06 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $21.22 million versus the consensus estimate of $22.13 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- Jabil beats consensus estimates but shares dip
- Laser Photonics Corporation (LASE) Reports Q1 Loss of $0.11
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
